PaxMedica (PXMD) Competitors $0.08 +0.00 (+5.00%) (As of 12/20/2024 03:15 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrends PXMD vs. INM, PTIX, ATXI, CHRO, SNOA, PCSA, PRTG, KTTA, ONCO, and ARTLShould you be buying PaxMedica stock or one of its competitors? The main competitors of PaxMedica include InMed Pharmaceuticals (INM), Protagenic Therapeutics (PTIX), Avenue Therapeutics (ATXI), Chromocell Therapeutics (CHRO), Sonoma Pharmaceuticals (SNOA), Processa Pharmaceuticals (PCSA), Portage Biotech (PRTG), Pasithea Therapeutics (KTTA), Onconetix (ONCO), and Artelo Biosciences (ARTL). These companies are all part of the "pharmaceutical products" industry. PaxMedica vs. InMed Pharmaceuticals Protagenic Therapeutics Avenue Therapeutics Chromocell Therapeutics Sonoma Pharmaceuticals Processa Pharmaceuticals Portage Biotech Pasithea Therapeutics Onconetix Artelo Biosciences InMed Pharmaceuticals (NASDAQ:INM) and PaxMedica (NASDAQ:PXMD) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, community ranking, institutional ownership, earnings, media sentiment and analyst recommendations. Which has better earnings and valuation, INM or PXMD? InMed Pharmaceuticals has higher revenue and earnings than PaxMedica. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInMed Pharmaceuticals$4.96M0.64-$7.68M-$13.91-0.32PaxMedicaN/AN/A-$18.29MN/AN/A Does the media refer more to INM or PXMD? In the previous week, InMed Pharmaceuticals had 1 more articles in the media than PaxMedica. MarketBeat recorded 1 mentions for InMed Pharmaceuticals and 0 mentions for PaxMedica. InMed Pharmaceuticals' average media sentiment score of 0.00 equaled PaxMedica'saverage media sentiment score. Company Overall Sentiment InMed Pharmaceuticals Neutral PaxMedica Neutral Do institutionals & insiders hold more shares of INM or PXMD? 20.1% of InMed Pharmaceuticals shares are held by institutional investors. Comparatively, 4.9% of PaxMedica shares are held by institutional investors. 1.9% of InMed Pharmaceuticals shares are held by insiders. Comparatively, 1.0% of PaxMedica shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the MarketBeat Community prefer INM or PXMD? InMed Pharmaceuticals received 7 more outperform votes than PaxMedica when rated by MarketBeat users. However, 100.00% of users gave PaxMedica an outperform vote while only 47.06% of users gave InMed Pharmaceuticals an outperform vote. CompanyUnderperformOutperformInMed PharmaceuticalsOutperform Votes847.06% Underperform Votes952.94% PaxMedicaOutperform Votes1100.00% Underperform VotesNo Votes Which has more volatility and risk, INM or PXMD? InMed Pharmaceuticals has a beta of 0.3, suggesting that its stock price is 70% less volatile than the S&P 500. Comparatively, PaxMedica has a beta of -0.55, suggesting that its stock price is 155% less volatile than the S&P 500. Is INM or PXMD more profitable? PaxMedica has a net margin of 0.00% compared to InMed Pharmaceuticals' net margin of -137.41%. InMed Pharmaceuticals' return on equity of -65.74% beat PaxMedica's return on equity.Company Net Margins Return on Equity Return on Assets InMed Pharmaceuticals-137.41% -65.74% -53.57% PaxMedica N/A -3,167.89%-560.35% SummaryInMed Pharmaceuticals beats PaxMedica on 9 of the 11 factors compared between the two stocks. Ad Crypto 101 MediaThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… Get PaxMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for PXMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PXMD vs. The Competition Export to ExcelMetricPaxMedicaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$879,000.00$6.57B$5.14B$9.08BDividend YieldN/A2.99%5.09%4.23%P/E RatioN/A10.5990.1317.19Price / SalesN/A196.061,116.25117.05Price / CashN/A57.1643.1037.85Price / Book0.175.094.784.78Net Income-$18.29M$151.83M$120.31M$225.60M7 Day PerformanceN/A-2.14%-1.92%-1.23%1 Month PerformanceN/A-4.56%13.65%0.46%1 Year PerformanceN/A8.87%28.34%15.24% PaxMedica Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PXMDPaxMedicaN/A$0.08+5.0%N/A-90.3%$879,000.00N/A0.002Gap UpINMInMed Pharmaceuticals0.4358 of 5 stars$5.23-0.6%N/A-36.5%$3.76M$4.96M-0.3813News CoveragePositive NewsGap DownPTIXProtagenic Therapeutics0.8347 of 5 stars$0.54+9.1%N/A-27.7%$3.67MN/A-0.391Positive NewsGap UpATXIAvenue Therapeutics2.1972 of 5 stars$1.77-1.4%N/A-83.3%$3.64MN/A0.104CHROChromocell TherapeuticsN/A$0.60+2.5%N/AN/A$3.62MN/A0.004SNOASonoma Pharmaceuticals0.5922 of 5 stars$2.69+0.7%N/A+1,608.9%$3.61M$12.73M0.00180PCSAProcessa Pharmaceuticals3.0449 of 5 stars$1.09-1.8%$6.00+450.5%-88.4%$3.56MN/A-0.3320News CoverageGap DownPRTGPortage Biotech1.3517 of 5 stars$3.31+10.3%N/A-76.2%$3.48MN/A-0.076Gap DownKTTAPasithea TherapeuticsN/A$2.74+3.4%N/A-55.1%$3.47M$20,000.000.003ONCOOnconetix0.1436 of 5 stars$0.42+3.7%N/AN/A$3.46M$1.87M0.0012ARTLArtelo Biosciences2.072 of 5 stars$1.06-4.9%$5.50+420.8%-31.3%$3.41MN/A-0.395News Coverage Related Companies and Tools Related Companies INM Alternatives PTIX Alternatives ATXI Alternatives CHRO Alternatives SNOA Alternatives PCSA Alternatives PRTG Alternatives KTTA Alternatives ONCO Alternatives ARTL Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PXMD) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PaxMedica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PaxMedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
